{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T19:44:43Z","timestamp":1775159083578,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.cyto.2014.05.016","type":"journal-article","created":{"date-parts":[[2014,6,8]],"date-time":"2014-06-08T00:00:54Z","timestamp":1402185654000},"page":"56-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["In situ cytokines (IL-4, IL-10, IL-12, IFN-\u03b3) and chemokines (MCP-1, MIP-1\u03b1) gene expression in human Leishmania (Leishmania) mexicana infection"],"prefix":"10.1016","volume":"69","author":[{"given":"Guillermo","family":"Valencia-Pacheco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsy Nalleli","family":"Lor\u00eda-Cervera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika Ivett","family":"Sosa-Bibiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsy B.","family":"Canch\u00e9-Pool","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Vargas-Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter C.","family":"Melby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando J.","family":"Andrade-Narvaez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2014.05.016_b0005","doi-asserted-by":"crossref","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cyto.2014.05.016_b0010","unstructured":"Control of the leishmaniasis: report of a meeting of the WHO expert committee on the control of leishmaniases, Geneva, 22\u201326 March 2010 (WHO technical report series no. 949)."},{"key":"10.1016\/j.cyto.2014.05.016_b0015","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1086\/382077","article-title":"Combating tropical infectious diseases: report of the disease control priorities in developing countries project","volume":"38","author":"Hotez","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cyto.2014.05.016_b0020","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1371\/journal.pmed.0030102","article-title":"Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV\/AIDS, tuberculosis, and malaria","volume":"3","author":"Hotez","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.cyto.2014.05.016_b0025","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/00034983.1912.11687069","article-title":"Leishmaniasis and babesiasis in Yucatan","volume":"6","author":"Seidelin","year":"1912","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.cyto.2014.05.016_b0030","first-page":"385","article-title":"Sintesis de 70 historias cl\u00ednicas de leishmaniasis tegumentaria en M\u00e9xico (\u00falcera de los chicleros)","volume":"33","author":"Biagi","year":"1953","journal-title":"Medicina (Mexico)"},{"key":"10.1016\/j.cyto.2014.05.016_b0035","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1590\/S0074-02762001000200005","article-title":"Clinical picture of cutaneous leishmaniasis due to Leishmania (Leishmania) mexicana in the Yucatan Peninsula, Mexico","volume":"96","author":"Andrade-Narvaez","year":"2001","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.cyto.2014.05.016_b0040","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1590\/S0074-02762003000800002","article-title":"Seasonal transmission of Leishmania (Leishmania) mexicana in the State of Campeche, Yucatan Peninsula, Mexico","volume":"98","author":"Andrade-Narvaez","year":"2003","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.cyto.2014.05.016_b0045","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0035-9203(90)90262-D","article-title":"Incidence of localized cutaneous leishmaniasis (Chiclero\u2019s ulcer) in Mexico","volume":"84","author":"Andrade-Narv\u00e1ez","year":"1990","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.cyto.2014.05.016_b0050","unstructured":"Arjona-Villica\u00f1a RD. Prevalencia de infecci\u00f3n subcl\u00ednica por Leishmania en una poblaci\u00f3n de alto riesgo de leishmaniosis cut\u00e1nea en el estado de Campeche. MD thesis. Universidad Aut\u00f3noma de Yucat\u00e1n; 2002."},{"key":"10.1016\/j.cyto.2014.05.016_b0055","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(05)67629-5","article-title":"Advances in leishmaniasis","volume":"366","author":"Murray","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2014.05.016_b0060","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1086\/340261","article-title":"Epidemiologic and immunologic findings for the subclinical form of Leishmania braziliensis infection","volume":"34","author":"Follador","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cyto.2014.05.016_b0065","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1590\/S0074-02762007005000069","article-title":"T-cell responses associated with resistance to Leishmania infection in individuals from endemic areas for Leishmania (Viannia) braziliensis","volume":"102","author":"Bittar","year":"2007","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.cyto.2014.05.016_b0070","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1086\/653829","article-title":"T-bet, GATA-3, and Foxp3 expression and Th1\/Th2 cytokine production in the clinical outcome of human infection with Leishmania (Viannia) species","volume":"202","author":"D\u0131az","year":"2010","journal-title":"J Infect Diseases"},{"key":"10.1016\/j.cyto.2014.05.016_b0075","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.pt.2004.05.005","article-title":"Virulence and disease in leishmaniasis: what is relevant for the patient?","volume":"20","author":"Rivas","year":"2004","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.cyto.2014.05.016_b0080","doi-asserted-by":"crossref","first-page":"5442","DOI":"10.1128\/IAI.64.12.5442-5445.1996","article-title":"Effects of sand fly vector saliva on development of cutaneous lesions and the immune response to Leishmania braziliensis in BALB\/c mice","volume":"64","author":"Lima","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.cyto.2014.05.016_b0085","doi-asserted-by":"crossref","unstructured":"Blackwell JM, Fakiola M, Ibrahim ME, Jamieson SE, Jeronimo SB, Miller EN, et al. Genetics and visceral leishmaniasis: of mice and man. Parasite Immunol http:\/\/dx.doi.org\/10.1111\/j.1365-3024.2009.01102.x.","DOI":"10.1111\/j.1365-3024.2009.01102.x"},{"key":"10.1016\/j.cyto.2014.05.016_b0090","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1128\/IAI.71.5.2674-2683.2003","article-title":"The levels and patterns of cytokines produced by CD4 T lymphocytes of BALB\/c mice infected with Leishmania major by inoculation into the ear dermis depend on the infectiousness and size of the inoculums","volume":"71","author":"Lang","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.cyto.2014.05.016_b0095","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1128\/IAI.62.3.837-842.1994","article-title":"Increased expression of proinflamatory cytokines in chronic lesions of human CL","volume":"62","author":"Melby","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.cyto.2014.05.016_b0100","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1574-695X.1996.tb00059.x","article-title":"In situ expression of Interleukin-10 and Interleukin-12 in active human cutaneous leishmaniasis","volume":"15","author":"Melby","year":"1996","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.cyto.2014.05.016_b0105","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0014-5793(89)80590-3","article-title":"Human monocyte chemotactic protein-1 (MCP-1): full-length cDNA cloning expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence","volume":"244","author":"Yoshimura","year":"1987","journal-title":"FEBS Lett"},{"key":"10.1016\/j.cyto.2014.05.016_b0110","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1084\/jem.169.4.1485","article-title":"Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line","volume":"169","author":"Matsushima","year":"1989","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2014.05.016_b0115","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1590\/S0074-02761999000300005","article-title":"Use of monoclonal antibodies for the identification of Lesihmania spp. from humans and wild rodents in the State of Campeche, Mexico","volume":"94","author":"Canto-Lara","year":"1999","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.cyto.2014.05.016_b0120","doi-asserted-by":"crossref","first-page":"960","DOI":"10.4269\/ajtmh.1999.61.960","article-title":"Cutaneous leishmaniasis (chicler\u00f3s ulcer\u201d) response to treatment with meglumine antimoniate in southeast Mexico","volume":"61","author":"Vargas-Gonzalez","year":"1999","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.cyto.2014.05.016_b0125","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1046\/j.1365-3083.2000.00724.x","article-title":"Distinct innate and acquired immune responses to Leishmania in putative susceptible and resistant human populations endemically exposed to L. (Viannia) panamensis infection","volume":"51","author":"Bosque","year":"2000","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.cyto.2014.05.016_b0130","doi-asserted-by":"crossref","first-page":"730","DOI":"10.4049\/jimmunol.155.2.730","article-title":"Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating Leishmaniosis in normally resistant mice","volume":"155","author":"Heinzel","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2014.05.016_b0135","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1084\/jem.173.4.869","article-title":"Induction of IFN-\u03b3 production by NK cell stimulatory factor (NKSF): characterization of responder cells and synergy with other inducers","volume":"173","author":"Chan","year":"1991","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2014.05.016_b0140","first-page":"1847","article-title":"Identification and purification of NK cell stimulatory factor (NKSF) a cytokine with multiple biologic effects on human lymphocytes","volume":"83","author":"Kobayashi","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2014.05.016_b0145","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0167-5699(93)90230-I","article-title":"Interleukin-12 and its role in the generation of Th1 cells","volume":"14","author":"Trinchieri","year":"1993","journal-title":"Immunol Today"},{"key":"10.1016\/j.cyto.2014.05.016_b0150","first-page":"423","article-title":"Immunoregulation by IL-12","volume":"146","author":"Trinchieri","year":"1995","journal-title":"Head Immunol"},{"key":"10.1016\/j.cyto.2014.05.016_b0155","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1086\/515297","article-title":"Immunologic determinants of disease evolution in localized cutaneous leishmaniasis due to Leishmania major","volume":"177","author":"Louzir","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cyto.2014.05.016_b0160","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.4049\/jimmunol.146.10.3444","article-title":"IL-10 acts on antigen presenting cell to inhibit cytokines production by Th1 cells","volume":"146","author":"Fiorentino","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2014.05.016_b0165","doi-asserted-by":"crossref","first-page":"A49","DOI":"10.1016\/S0167-5699(05)80015-5","article-title":"The role of IL-10 in cross-regulation of Th1 and Th2 responses","volume":"12","author":"Mosmann","year":"1991","journal-title":"Immunol Today"},{"key":"10.1016\/j.cyto.2014.05.016_b0170","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1084\/jem.178.3.1041","article-title":"Interleukin-10 inhibits human lymphocyte interferon gamma production by suppressing NK cell stimulatory factor\/interleukin-12 synthesis in accessory cells","volume":"178","author":"D\u2019Andrea","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2014.05.016_b0175","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1084\/jem.174.6.1549","article-title":"Macrophage deactivation by interleukin-10","volume":"174","author":"Bogdan","year":"1991","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2014.05.016_b0180","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.4049\/jimmunol.147.11.3815","article-title":"IL-10 inhibits cytokine production by activated macrophages","volume":"147","author":"Fiorentino","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2014.05.016_b0185","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.4049\/jimmunol.147.9.3149","article-title":"IFN-\u03b3 modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis","volume":"147","author":"Scott","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2014.05.016_b0190","first-page":"506","article-title":"Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes: evidence that interferon-gamma is activating lymphokine","volume":"72","author":"Murray","year":"1983","journal-title":"J Clin Inv"},{"key":"10.1016\/j.cyto.2014.05.016_b0195","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1084\/jem.179.4.1367","article-title":"CD4+ effectors cells default to the Th2 pathway in the interferon gamma deficient mice infected with Leishmania major","volume":"179","author":"Wang","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2014.05.016_b0200","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1084\/jem.181.3.961","article-title":"Mice from a genetically resistant background lacking the interferon gamma receptor are susceptible to infection with Leishmania major but mount a polarized T helper cell 1-type CD4+ T cell response","volume":"181","author":"Swihart","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2014.05.016_b0205","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/eji.1830240328","article-title":"Production of nitric oxidizes and superoxide by activated macrophages and killing of Leishmania major","volume":"24","author":"Asseruy","year":"1994","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.cyto.2014.05.016_b0210","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1146\/annurev.iy.09.040191.003153","article-title":"Properties of the novel proinflammatory supergene intercrine cytokine family","volume":"9","author":"Oppenheim","year":"1991","journal-title":"Ann Rev Immunol"},{"key":"10.1016\/j.cyto.2014.05.016_b0215","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.pt.2005.11.010","article-title":"Chemokines in host\u2013parasite interactions in leishmaniasis","volume":"22","author":"Teixeira","year":"2006","journal-title":"Trends in Parasitol"},{"key":"10.1016\/j.cyto.2014.05.016_b0220","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.4049\/jimmunol.148.9.2764","article-title":"Macrophage inflammatory protein 1 modulates macrophage functions","volume":"48","author":"Fahey","year":"1992","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2014.05.016_b0225","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/infdis\/173.3.699","article-title":"Differential expression of chemokines in patients with localized and diffuse cutaneous American leishmaniasis","volume":"173","author":"Ritter","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cyto.2014.05.016_b0230","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1002\/1521-4141(200011)30:11<3111::AID-IMMU3111>3.0.CO;2-O","article-title":"Monocyte chemotactic protein-1 stimulates the killing of Leishmania major by human monocytes, acts synergistically with IFN-q and is antagonized by IL-4","volume":"30","author":"Ritter","year":"2000","journal-title":"Eur J Immunol"},{"issue":"5","key":"10.1016\/j.cyto.2014.05.016_b0235","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.meegid.2010.04.006","article-title":"The -2518 bp promoter polymorphism at CCL2\/MCP1 influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil","volume":"10","author":"Ramasawmya","year":"2010","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.cyto.2014.05.016_b0240","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1128\/IAI.71.3.1587-1589.2003","article-title":"Interleukin-12 regulates chemokine gene expression during early reponse to Leishmania major","volume":"71","author":"Zaph","year":"2003","journal-title":"Infect Immun"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466614001495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466614001495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T01:39:54Z","timestamp":1689298794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466614001495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S1043466614001495"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2014.05.016","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In situ cytokines (IL-4, IL-10, IL-12, IFN-\u03b3) and chemokines (MCP-1, MIP-1\u03b1) gene expression in human Leishmania (Leishmania) mexicana infection","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2014.05.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}